http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
V2V 통신 환경에서 DoS 공격 탐지 모델 개발을 위한 데이터 생성 및 검증
이현로(Hyeonro Lee),이민종(Minjong Lee),하재철(Jaecheol Ha) 한국산학기술학회 2024 한국산학기술학회논문지 Vol.25 No.1
In recent years, autonomous vehicles have been using deep learning to recognize road conditions and make driving decisions. In addition, autonomous driving that uses only deep learning technology has limitations, so it utilizes vehicular ad-hoc network (VANET) communications. However, VANET communications contains vulnerabilities that can be exposed to cyber-attacks such as denial of service (DoS), and research is underway to defend against them. In this paper, we generate a dataset to develop a machine learning model that can detect DoS attacks in the V2V communications environment of VANETs. The dataset is generated using simulation tools, such as OMNeT++, SUMO, Veins, and INET, to reflect the attributes of V2V communications and characteristics of the attacks. In addition, the attack dataset generated is validated to see if attacks can be detected by various machine learning models. The evaluation results show that the generated dataset can detect DoS attacks with an accuracy of about 97% or higher from most of the trained machine learning models, which is useful for training intrusion detection models.
다발성 간 전이를 보인 글루카곤종에서 Sunitinib 치료 후 발생한 중성구감소증
문홍란 ( Hong Ran Moon ),최지민 ( Ji Min Choi ),장동기 ( Dong Kee Jang ),이민종 ( Minjong Lee ) 대한내과학회 2013 대한내과학회지 Vol.84 No.3
Pancreatic neuroendocrine tumors (PNET) are rare, with approximately 2.2 in 1,000,000 people affected annually. In the classification of neuroendocrine tumors, glucagonomas are a functional PNET and comprise 1.6% of PNET. Glucagonoma syndrome is a paraneoplastic syndrome that is characterized by necrolytic migratory erythema, weight loss, anemia, and diabetes mellitus. Metastatic disease at presentation is common, but is often limited to the liver and regional lymph nodes. Sunitinib malate improves the progression-free and overall survival of PNET. This report presents a 45-year-old Asian woman with prolonged neutropenia after sunitinib treatment of a glucagonoma with multiple hepatic metastases. The severity of the neutropenia after the sunitinib treatment fluctuated from grade 1 to 4 repeatedly, with a non-febrile pattern. Ultimately, the patient did not recover from the neutropenia, even after stopping the sunitinib. (Korean J Med 2013;84:405-410)